Stratview Research has recently published a report on the Fibrinogen Concentrate Market. This strategically evaluated report provides a detailed overview that presents today's market scenario and future possibilities, as well as market intelligence and information, for a 5-year period from 2022 to 2028.

The market is segmented By Type (Human Fibrinogen Concentrates, Animal Fibrinogen Concentrates), Application (Hospitals, Ambulatory Surgical Centers, Others), and Region

Fibrinogen Concentrate Market Analysis:

Stratview Research’s report discusses the segment-wise current market condition. Also, it offers an estimation of future growth opportunities. As per the estimation, the Fibrinogen Concentrate Market is estimated to grow from USD 2.79 billion in 2021 to USD 4.09 billion by 2028 at a healthy CAGR of 5.53% during the forecast period.

Some of the companies drive the market growth:

• Green Cross Corporation (South Korea),
• Octapharma AG (Switzerland),
• The LFB group (France),
• Thermo Fisher Scientific (The U.S),
• The Merck Group (Germany),
• Affinity Biologicals Inc (Canada),
• Cayman Chemical Company (The U.S),
• Molecular Innovations (The U.S),
• CSL Limited (Australia),
• AkronBiotech (The U.S),
• Enzo Life Sciences, Inc. (The U.S) and
• Bovogen Biologicals Pty Ltd. (Australia).

To download a free sample of the report, Click Here: https://www.stratviewresearch.com/Request-Sample/2009/Fibrinogen-Concentrate-Market.html#form

Segments Analysis

Application Trends

The market has been bifurcated into hospitals, ambulatory surgical centers and others. Under these, the hospitals segment accounted for the largest market share in 2021 and is projected to register significant growth during the review period on account of presence of established healthcare infrastructure and professional healthcare staff.

Regional Analysis

The market in North America accounted for the largest market share in 2021 and is projected to grow at a significant CAGR during the assessment period. The regional growth can be attributed to increasing incidences of blood related disorders and presence of key market players such as Thermo Fisher Scientific (The U.S) and Cayman Chemical Company (The U.S). The market progress in Asia-Pacific region is expected to be driven by increasing use of fibrinogen concentrate in treating congenital deficiencies.

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.